silica nanocapsules

Researchers at UW–Madison have engineered silicone nanoparticles to cross the blood-brain barrier in mice to deliver brain-wide gene editing therapy for Alzheimer’s disease. PHOTO: JEFF MILLER
Nanoparticles can cross the blood-brain barrier with a range of biological medications and treatments to deliver brain-wide therapy